Gastrodin Inhibits Store-Operated Ca2+ Entry and Alleviates Cardiac Hypertrophy

• Main Authors: Xiaoqiang Yao (Author), Changbo Zheng (Author), Chun-Yin Lo (Author), Zhaoyue Meng (Author), Zhichao Li (Author), Mingkui Zhong (Author), Peng Zhang (Author), Jun Lu (Author), Zhaoxiang Yang (Author), Fuman Yan (Author), Yunting Zhang (Author), Yu Huang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cardiac hypertrophy is a major risk factor for heart failure, which are among the leading causes of human death. Gastrodin is a small molecule that has been used clinically to treat neurological and vascular diseases for many years without safety issues. In the present study, we examined protective...